1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
(
- Contribution to journal › Article
- 2019
-
Mark
The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model
(
- Contribution to journal › Article
- 2014
-
Mark
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
(
- Contribution to journal › Article
- 2013
-
Mark
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
(
- Contribution to journal › Article
- 2012
-
Mark
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
(
- Contribution to journal › Article
- 2009
-
Mark
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8(+) and CD4(+) T-cells.
(
- Contribution to journal › Article